 BEIJING, Sept. 27, 2021 GLOBE NEWSWIRE -- Genetron Holdings Limited Genetron Health or the Company, NASDAQ: GTH, a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnostics development, today announced a partnership with IMPACT Therapeutics, a biopharmaceutical company dedicated to the discovery and development of targeted anti-cancer therapeutics. 